Pharmaceuticals

ITERUM THERAPEUTICS PLC

ITRMF.US released FY2025 Q3 earnings on November 14 Pre-Market (BJT), actual revenue USD 390K, actual EPS USD -0.196

ITRMF.US released FY2024 Q2 earnings on August 5 Pre-Market (BJT), actual revenue USD 0, actual EPS USD -0.3018

ITERUM THERAPEUTICS PLC released FY2024 Q1 earnings on May 13 Pre-Market (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.4601 (forecast USD --)

ITERUM THERAPEUTICS PLC released FY2025 9 Months earnings on November 14 Pre-Market (EST), actual revenue USD 390K, actual EPS USD -0.5026

ITERUM THERAPEUTICS PLC released FY2024 Semi-Annual earnings on August 5, Pre-Market EST, with actual revenue of USD 0 and EPS of USD -0.7564

ITERUM THERAPEUTICS PLC released FY2025 Q2 earnings on August 5 Pre-Market EST, with actual revenue USD 0 and actual EPS USD -0.1629

ITRMF.US released FY2024 9 Months Earnings on November 14 Pre-Market (BJT), Actual Revenue USD 0, Actual EPS USD -1.066

ITRMF.US released FY2025 Q1 earnings on May 13 Pre-Market (BJT), actual revenue USD 0, actual EPS USD -0.1436

ITERUM THERAPEUTICS PLC released FY2025 Semi-Annual Earnings on August 5, Pre-Market EST, with actual revenue of USD 0 and EPS of USD -0.3079

ITERUM THERAPEUTICS PLC released FY2024 Q3 earnings on November 14 Pre-Market EST, actual revenue USD 0 (forecast USD 0), actual EPS USD -0.304 (forecast USD --)

ITRMF

Visionary

Sky Quarry

TMD Energy

AMPLITECH GROUP INC. USD0.001 S/R 20/11/26 SER B

Semilux

Cocrystal Pharma

Sidus Space

Swarmer

Franklin Covey

Biodexa Pharmaceuticals

Eli Lilly

ROCHE HOLDINGS AG

Roche

AstraZeneca

NOVARTIS AG

Novo Nordisk AS

Chugai Pharmaceutical

UCB S.A.

Otsuka Pharmaceutical

Daiichi Sankyo

Style Score

Growth Score

Revenue YoY

Net Profit YoY

Value Score

P/B Ratio

Dividend Ratio

Size Score

Market Cap Score

Market Cap

Revenue Score

Revenue

Multi Score

Profit Score

Profit Margin

Gross Margin

Total Assets YoY

Net Assets YoY

Cash Score

Cash Flow Margin

OCF YoY

Operating Score

Turnover

Debt Score

Gearing Ratio

Please note that a "Suspected value trap" is a stock that appears The stock looks financially sound and severely undervalued, but behind the low valuation is a long-term decline in business capacity or a serious financial crisis, or even the risk of bankruptcy in the short term.

Suspected value trap

ITERUM THERAPEUTICS PLC(ITRMF.US)

ITERUM THERAPEUTICS PLC Stock Performance Chart